Lv31
263 积分 2021-04-02 加入
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
5小时前
待确认
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial
9天前
已完结
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
10天前
已完结
Indications and Parameters Around Postoperative Radiation Therapy for Lung Cancer
10天前
已完结
The landscape of cancer research and cancer care in China
11天前
已完结
Clinical, Imaging, and Pathological-Molecular Characteristics Associated with Stage IA Invasive Lung Adenocarcinoma Recurrence After Sub-lobar Resection
14天前
已完结
[Advances in pathological evaluation of non-small-cell lung carcinoma after neoadjuvant therapy]
14天前
已完结
Comparison of different criteria for estimating major pathological response in resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy
14天前
已完结
我国三级肿瘤医院多学科诊疗模式开展现状调查
22天前
已完结
[Advances in pathological evaluation of non-small-cell lung carcinoma after neoadjuvant therapy]
28天前
已完结
皖公网安备34019202002308
